» Articles » PMID: 17268850

Salsolinol, an Endogenous Neurotoxin, Activates JNK and NF-kappaB Signaling Pathways in Human Neuroblastoma Cells

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 2007 Feb 3
PMID 17268850
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Salsolinol, an endogenous neurotoxin, is known to be involved in the pathogenesis of Parkinson's disease (PD). In the present study, we have investigated the effects of salsolinol on the activation of two different signaling pathways that involve c-Jun N-terminal kinase (JNK), and nuclear factor-kappaB, (NF-kappaB) in human dopaminergic neuroblastoma SH-SY5Y cells. Salsolinol treatment caused upregulation in the levels of c-Jun and phosphorylated c-Jun. It also caused degradation of IkappaBalpha and translocated the active NF-kappaB into the nucleus. The binding activity of NF-kappaB to DNA was enhanced by salsolinol in a concentration dependent manner. Furthermore, salsolinol decreased the levels of the anti-apoptotic protein Bcl-2, and increased pro-apoptotic protein Bax, while enhancing the release of cytochrome-c from mitochondria. Mitochondrial complex-I activity was significantly decreased and reactive oxygen species (ROS) were increased in salsolinol treated cells. These results partly suggest that salsolinol-induced JNK and NF-kappaB signaling pathways may be involved in induction of apoptosis in human dopaminergic neurons, as seen in Parkinson's disease.

Citing Articles

Neuroprotective Activity of Enantiomers of Salsolinol and -Methyl-()-salsolinol: In Vitro and In Silico Studies.

Kurnik-Lucka M, Latacz G, Bucki A, Rivera-Meza M, Khan N, Konwar J ACS Omega. 2023; 8(41):38566-38576.

PMID: 37867702 PMC: 10586258. DOI: 10.1021/acsomega.3c05527.


as Potential Anticancer Herb: Bioactive Compounds and Molecular Mechanisms.

Zhang W, Lu C, Cai S, Feng Y, Shan J, Di L Front Pharmacol. 2022; 13:870282.

PMID: 35662730 PMC: 9158441. DOI: 10.3389/fphar.2022.870282.


Cytokinin Plant Hormones Have Neuroprotective Activity in In Vitro Models of Parkinson's Disease.

Gonzalez G, Gruz J, DAcunto C, Kanovsky P, Strnad M Molecules. 2021; 26(2).

PMID: 33445611 PMC: 7827283. DOI: 10.3390/molecules26020361.


Salsolinol-neurotoxic or Neuroprotective?.

Kurnik-Lucka M, Latacz G, Martyniak A, Bugajski A, Kiec-Kononowicz K, Gil K Neurotox Res. 2019; 37(2):286-297.

PMID: 31732870 PMC: 6989573. DOI: 10.1007/s12640-019-00118-7.


Salsolinol: an Unintelligible and Double-Faced Molecule-Lessons Learned from In Vivo and In Vitro Experiments.

Kurnik-Lucka M, Panula P, Bugajski A, Gil K Neurotox Res. 2017; 33(2):485-514.

PMID: 29063289 PMC: 5766726. DOI: 10.1007/s12640-017-9818-6.

References
1.
Lei K, Nimnual A, Zong W, Kennedy N, Flavell R, Thompson C . The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol. 2002; 22(13):4929-42. PMC: 133923. DOI: 10.1128/MCB.22.13.4929-4942.2002. View

2.
Chen Z, HAGLER J, Palombella V, MELANDRI F, Scherer D, Ballard D . Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 1995; 9(13):1586-97. DOI: 10.1101/gad.9.13.1586. View

3.
Verheij M, Bose R, Lin X, Yao B, Jarvis W, Grant S . Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 1996; 380(6569):75-9. DOI: 10.1038/380075a0. View

4.
Jenkins R, OShea R, Thomas K, Hunt S . c-jun expression in substantia nigra neurons following striatal 6-hydroxydopamine lesions in the rat. Neuroscience. 1993; 53(2):447-55. DOI: 10.1016/0306-4522(93)90208-w. View

5.
Morgan J, Curran T . Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci. 1991; 14:421-51. DOI: 10.1146/annurev.ne.14.030191.002225. View